Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.43 |
| ▸ | NPY1R | P25929 | 9/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.43 |
| ▸ | NPY2R | P49146 | 5/20 | 0.43 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.38 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15011349 | 0.97 | NPY4R (0.40) | NPY4RNPY1RNPY5RNPY2RNOD1 | |
| SCHEMBL9614927 | 0.97 | NPY4R (0.40) | NPY4RNPY1RNPY5RNPY2RNOD1 | |
| SCHEMBL27732271 | 0.97 | NPY4R (0.40) | NPY4RNPY1RNPY5RNPY2RNOD1 | |
| SCHEMBL30484000 | 0.96 | NPY4R (0.41) | NPY4RNPY1RNPY5RNPY2RNOD1 | |
| SCHEMBL30855541 | 0.94 | NPY4R (0.40) | NPY4RNPY1RNPY5RNPY2RNOD1 | |
| SCHEMBL31277463 | 0.94 | ENPEP (0.46) | ENPEP | |
| SCHEMBL29619336 | 0.94 | CPB2 (0.45) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL6038374 | 0.94 | NPY4R (0.40) | NPY4RNPY1RNPY5RNPY2RNOD1 | |
| SCHEMBL30912042 | 0.94 | NPY4R (0.42) | NPY4RNPY1RNPY5RNPY2RNOD1 | |
| SCHEMBL30303032 | 0.94 | ENPEP (0.46) | ENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195611-A1 | ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF | PEPTILOGICS, INC. | 2025-06-19 | — | — | US | disclosed |
| US-20250099514-A1 | FISH REARING COMPOSITION, AND COMPOSITION FOR PREVENTING OR TREATING FISH DISEASES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-03-27 | — | — | US | disclosed |
| EP-4413867-A1 | FISH REARING COMPOSITION, AND COMPOSITION FOR TREATING OR PREVENTING FISH DISEASES | Sumitomo Chemical Company, Limited (JP) | 2024-08-14 | — | — | EP | disclosed |
| US-20240252586-A1 | ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF | PEPTILOGICS, INC. | 2024-08-01 | — | — | US | disclosed |
| CN-117915781-A | Composition for fish farming and composition for preventing or treating fish diseases | 住友化学株式会社 | 2024-04-19 | — | — | CN | disclosed |
| US-20230106943-A1 | ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF | PEPTILOGICS, INC. | 2023-04-06 | — | — | US | disclosed |
| WO-2023282355-A1 | FISH REARING COMPOSITION, AND COMPOSITION FOR TREATING OR PREVENTING FISH DISEASES | 住友化学株式会社 | 2023-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250195611-A1 | ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF | VIP, SPPL2B, HM13 | NPY4R 2434/4885NPY1R 2661/4885NPY5R 2862/4885 |
| US-20230106943-A1 | ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF | VIP, SPPL2B, HM13 | NPY4R 2434/4885NPY1R 2661/4885NPY5R 2862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.